Peptides MEX / Comparisons
TB-500 vs GHK-Cu: peptide fragment and copper complex
The comparison begins with distinct identities: Ac-LKKTETQ was the fragment detected in a TB-500 material, whereas GHK-Cu is a copper–tripeptide complex. The selected sources provide analytical characterization for one and extracellular-matrix experiments for the other.
Updated · Sources and editorial standards
| Feature | TB-500 | GHK-Cu |
|---|---|---|
| Described entity[1][2] | Acetylated Ac-LKKTETQ fragment in the studied sample | Glycine-histidine-lysine complex with copper |
| Chemical feature[1][2] | N-terminal acetylation | Association with Cu(II) |
| Featured evidence[3][4] | Identification and metabolite detection | Matrix synthesis and accumulation |
Acetylation and copper coordination
In the fragment identified as TB-500, Ac denotes an acetyl modification at the N-terminus of LKKTETQ. In GHK-Cu, Cu denotes copper associated with glycine-histidine-lysine. These are different chemical features: a peptide modification and a metal complex should not be conflated when comparing composition.
Identifying a molecule and measuring its biological response
Mass spectrometry identified the TB-500 fragment; another paper studied its detection and metabolites in horses. The GHK-Cu fibroblast publication instead evaluated collagen synthesis. The former evidence answers which substance was detected; the latter answers what occurred within a particular culture.
Extracellular matrix and the limits of comparison
The GHK-Cu rat-wound experiment measured components including collagen and glycosaminoglycans. It did not include the TB-500 fragment as a comparator. Likewise, a publication about full-length thymosin β4 cannot automatically become evidence for the fragment. These distinctions prevent a clinical skin-repair ranking between the two.
Questions about this reference
Is TB-500 a copper peptide?
The fragment identified in the analytical study is Ac-LKKTETQ. That designation does not describe the GHK-Cu tripeptide–copper complex; the two entities have different compositions.
Sources and original reading
- Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+
- Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry
- In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds
Content updated: . How this content is prepared and checked.